Free Trial
→ Trump’s New Dollar revealed (From Porter & Company) (Ad)tc pixel Free UHT Stock Alerts

Universal Health Realty Income Trust (UHT) Financials

Universal Health Realty Income Trust logo
$41.30 +0.92 (+2.27%)
Closing price 06/5/2026 03:59 PM Eastern
Extended Trading
$41.21 -0.09 (-0.21%)
As of 06/5/2026 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Universal Health Realty Income Trust

Annual Income Statements for Universal Health Realty Income Trust

This table shows Universal Health Realty Income Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 21 15 19
Consolidated Net Income / (Loss)		 21 15 19
Net Income / (Loss) Continuing Operations		 32 32 38
Total Pre-Tax Income 		31 31 37
Total Revenue		 91 95 99
Net Interest Income / (Expense)		 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00
Total Non-Interest Income		 91 95 99
Other Service Charges		 3.19 2.50 2.29
Net Realized & Unrealized Capital Gains on Investments		 0.00 -0.23 0.00
Other Non-Interest Income		 87 93 97
Total Non-Interest Expense		 60 64 62
Other Operating Expenses		 33 36 35
Depreciation Expense		 27 28 27
Other Gains / (Losses), net		 1.19 1.21 1.28
Other Adjustments to Consolidated Net Income / (Loss)		 -11 -17 -19
Basic Earnings per Share		 $1.53 $1.12 $1.39
Weighted Average Basic Shares Outstanding		 13.77M 13.79M 13.80M
Diluted Earnings per Share		 $1.53 $1.11 $1.39
Weighted Average Diluted Shares Outstanding		 13.80M 13.81M 13.84M
Weighted Average Basic & Diluted Shares Outstanding		 13.80M 13.82M 13.85M
Cash Dividends to Common per Share		 $2.84 $2.88 $2.92

Quarterly Income Statements for Universal Health Realty Income Trust

This table shows Universal Health Realty Income Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 4.85 5.63 4.46 3.48 3.87 3.59 5.30 5.28 4.00 4.66
Consolidated Net Income / (Loss)		 4.85 5.63 4.46 3.48 3.87 3.59 5.30 5.28 4.00 4.66
Net Income / (Loss) Continuing Operations		 7.67 14 8.16 7.65 8.34 8.18 9.85 9.86 8.79 9.58
Total Pre-Tax Income 		7.32 8.73 7.79 7.38 8.03 7.92 9.46 9.58 8.49 9.26
Total Revenue		 22 24 23 24 24 24 25 25 24 25
Total Non-Interest Income		 22 24 23 24 24 24 25 25 24 25
Other Service Charges		 0.48 1.76 0.71 0.54 0.66 0.59 0.63 0.56 0.55 0.55
Other Non-Interest Income		 22 22 23 23 24 24 25 24 24 24
Total Non-Interest Expense		 15 11 15 16 16 16 16 15 16 15
Other Operating Expenses		 8.17 4.30 8.82 9.57 9.19 8.91 8.87 8.34 9.00 8.59
Depreciation Expense		 6.66 6.51 6.62 6.85 7.01 7.25 6.81 6.81 7.01 6.80
Other Gains / (Losses), net		 0.35 0.25 0.37 0.27 0.31 0.25 0.38 0.27 0.30 0.32
Other Adjustments to Consolidated Net Income / (Loss)		 -2.82 - -3.70 -4.18 -4.47 -4.58 -4.55 -4.58 -4.79 -4.92
Basic Earnings per Share		 $0.35 $0.41 $0.32 $0.25 $0.28 $0.27 $0.38 $0.38 $0.29 $0.34
Weighted Average Basic Shares Outstanding		 13.78M 13.77M 13.78M 13.78M 13.79M 13.79M 13.79M 13.80M 13.81M 13.80M
Diluted Earnings per Share		 $0.35 $0.41 $0.32 $0.25 $0.28 $0.26 $0.38 $0.38 $0.29 $0.34
Weighted Average Diluted Shares Outstanding		 13.80M 13.80M 13.80M 13.81M 13.82M 13.81M 13.82M 13.83M 13.85M 13.84M
Weighted Average Basic & Diluted Shares Outstanding		 13.80M 13.80M 13.80M 13.82M 13.82M 13.82M 13.83M 13.85M 13.85M 13.85M

Annual Cash Flow Statements for Universal Health Realty Income Trust

This table details how cash moves in and out of Universal Health Realty Income Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -15 0.60 -1.12
Net Cash From Operating Activities		 47 43 47
Net Cash From Continuing Operating Activities		 47 43 47
Net Income / (Loss) Continuing Operations		 21 15 19
Consolidated Net Income / (Loss)		 21 15 19
Depreciation Expense		 27 28 27
Amortization Expense		 0.52 0.55 0.59
Non-Cash Adjustments to Reconcile Net Income		 0.78 -0.76 0.85
Changes in Operating Assets and Liabilities, net		 -2.16 0.02 -1.19
Net Cash From Investing Activities		 -37 -19 -14
Net Cash From Continuing Investing Activities		 -37 -19 -14
Purchase of Property, Leasehold Improvements and Equipment		 -14 -7.62 0.00
Acquisitions		 -1.35 0.00 0.00
Purchase of Investment Securities		 -0.09 -4.06 -5.89
Sale and/or Maturity of Investments		 0.00 7.39 0.00
Other Investing Activities, net		 -22 -15 -7.98
Net Cash From Financing Activities		 -25 -23 -34
Net Cash From Continuing Financing Activities		 -25 -23 -34
Issuance of Debt		 26 29 22
Issuance of Common Equity		 0.18 0.15 -0.13
Repayment of Debt		 -12 -12 -14
Repurchase of Common Equity		 0.00 0.00 0.00
Payment of Dividends		 -39 -40 -40
Other Financing Activities, Net		 -0.03 -0.22 -2.38
Cash Interest Paid		 10 16 18

Quarterly Cash Flow Statements for Universal Health Realty Income Trust

This table details how cash moves in and out of Universal Health Realty Income Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 -0.30 -0.49 0.51 1.34 -1.10 -0.15 -0.52 -2.12 0.80 0.73
Net Cash From Operating Activities		 9.58 12 10 12 10 10 12 12 9.89 13
Net Cash From Continuing Operating Activities		 9.58 12 10 12 10 10 12 12 9.89 13
Net Income / (Loss) Continuing Operations		 4.85 5.63 4.46 3.48 3.87 3.59 5.30 5.28 4.00 4.66
Consolidated Net Income / (Loss)		 4.85 5.63 4.46 3.48 3.87 3.59 5.30 5.28 4.00 4.66
Depreciation Expense		 6.66 6.51 6.62 6.85 7.01 7.25 6.81 6.81 7.01 6.80
Amortization Expense		 0.13 0.13 0.12 0.13 0.14 0.16 0.15 0.15 0.15 0.15
Non-Cash Adjustments to Reconcile Net Income		 -0.49 1.61 -0.01 -0.22 0.81 -1.33 -0.18 0.59 -0.88 1.32
Changes in Operating Assets and Liabilities, net		 -1.57 -1.59 -1.12 2.02 -1.67 0.79 -0.34 -0.69 -0.38 0.23
Net Cash From Investing Activities		 -5.44 -5.43 -5.41 -3.48 -11 0.74 -8.95 -0.72 -1.50 -2.71
Net Cash From Continuing Investing Activities		 -5.44 -5.43 -5.41 -3.48 -11 0.74 -8.95 -0.72 -1.50 -2.71
Other Investing Activities, net		 -5.35 -5.43 -5.04 -3.48 -3.17 -3.14 -3.05 -0.72 -1.50 -2.71
Net Cash From Financing Activities		 -4.43 -7.35 -4.15 -7.43 -0.31 -11 -3.31 -14 -7.60 -9.72
Net Cash From Continuing Financing Activities		 -4.43 -7.35 -4.15 -7.43 -0.31 -11 -3.31 -14 -7.60 -9.72
Issuance of Debt		 5.80 8.00 10 3.00 10 5.10 7.05 9.25 4.85 1.15
Issuance of Common Equity		 0.04 0.04 0.04 0.04 0.04 0.03 0.04 -0.05 0.03 -0.15
Repayment of Debt		 -0.49 -5.54 -4.61 -0.38 -0.43 -6.47 -0.37 -13 -0.31 -0.32
Payment of Dividends		 -9.78 -9.85 -9.85 -9.99 -9.93 -10.00 -10 -10 -10 -10
Other Financing Activities, Net		 - - -0.03 -0.10 -0.09 - -0.03 -0.02 -2.08 -0.25
Cash Interest Paid		 2.72 3.34 3.72 4.01 4.30 4.23 3.76 4.46 4.92 4.77

Annual Balance Sheets for Universal Health Realty Income Trust

This table presents Universal Health Realty Income Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets		 608 596 581
Cash and Due from Banks		 7.61 8.21 7.10
Loans and Leases, Net of Allowance		 0.00 0.00 0.00
Premises and Equipment, Net		 461 455 437
Intangible Assets		 9.45 9.11 7.33
Other Assets		 107 124 130
Total Liabilities & Shareholders' Equity		 608 596 581
Total Liabilities		 378 395 401
Non-Interest Bearing Deposits		 11 11 11
Short-Term Debt		 298 327 349
Accrued Interest Payable		 0.37 0.49 0.69
Long-Term Debt		 45 33 19
Other Long-Term Liabilities		 24 24 21
Total Equity & Noncontrolling Interests		 229 201 180
Total Preferred & Common Equity		 229 201 180
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 229 201 180
Common Stock		 270 271 271
Retained Earnings		 -53 -77 -98
Accumulated Other Comprehensive Income / (Loss)		 12 7.31 6.41

Quarterly Balance Sheets for Universal Health Realty Income Trust

This table presents Universal Health Realty Income Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 609 604 603 608 596 587 584
Cash and Due from Banks		 8.10 8.12 9.46 8.36 7.70 5.58 6.37
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 461 459 458 461 450 445 441
Intangible Assets		 9.94 8.88 8.34 9.65 8.65 8.19 7.76
Other Assets		 107 107 107 107 130 128 129
Total Liabilities & Shareholders' Equity		 609 604 603 608 596 587 584
Total Liabilities		 376 382 386 398 400 396 403
Non-Interest Bearing Deposits		 9.91 11 11 12 11 11 11
Short-Term Debt		 290 308 311 322 334 343 348
Accrued Interest Payable		 0.35 0.34 0.34 0.33 1.09 1.02 0.74
Long-Term Debt		 50 40 40 39 33 20 20
Other Long-Term Liabilities		 25 22 24 25 21 21 24
Total Equity & Noncontrolling Interests		 234 222 217 210 196 191 182
Total Preferred & Common Equity		 234 222 217 210 196 191 182
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 234 222 217 210 196 191 182
Common Stock		 269 270 270 270 271 271 271
Retained Earnings		 -48 -58 -64 -70 -82 -86 -93
Accumulated Other Comprehensive Income / (Loss)		 13 10 11 10 7.50 6.44 3.26

Annual Metrics And Ratios for Universal Health Realty Income Trust

This table displays calculated financial ratios and metrics derived from Universal Health Realty Income Trust's official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 7.64% 5.21% 3.85%
EBITDA Growth		 1.48% 2.86% 9.11%
EBIT Growth		 6.24% 1.47% 18.25%
NOPAT Growth		 6.24% 1.47% 18.25%
Net Income Growth		 -80.67% -27.02% 24.90%
EPS Growth		 -80.68% -27.45% 25.23%
Operating Cash Flow Growth		 -1.93% -8.26% 9.25%
Free Cash Flow Firm Growth		 128.14% 86.77% 15.84%
Invested Capital Growth		 1.39% -2.02% -2.25%
Revenue Q/Q Growth		 3.09% -0.04% 0.56%
EBITDA Q/Q Growth		 10.56% -7.23% 1.37%
EBIT Q/Q Growth		 23.95% -14.78% 3.77%
NOPAT Q/Q Growth		 4.56% -2.53% 3.77%
Net Income Q/Q Growth		 -80.29% -11.69% 5.88%
EPS Q/Q Growth		 -80.28% -11.90% 6.11%
Operating Cash Flow Q/Q Growth		 1.65% -4.10% 6.10%
Free Cash Flow Firm Q/Q Growth		 138.94% 22.63% -14.14%
Invested Capital Q/Q Growth		 -0.36% -1.88% -0.23%
Profitability Metrics		 - - -
EBITDA Margin		 63.72% 62.30% 65.45%
EBIT Margin		 33.84% 32.64% 37.16%
Profit (Net Income) Margin		 23.29% 16.15% 19.43%
Tax Burden Percent		 68.81% 49.49% 52.27%
Interest Burden Percent		 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 5.40% 5.50% 6.64%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.55% 1.02% 1.81%
Return on Net Nonoperating Assets (RNNOA)		 3.69% 1.67% 3.47%
Return on Equity (ROE)		 9.09% 7.16% 10.11%
Cash Return on Invested Capital (CROIC)		 4.02% 7.53% 8.92%
Operating Return on Assets (OROA)		 5.09% 5.17% 6.25%
Return on Assets (ROA)		 3.50% 2.56% 3.27%
Return on Common Equity (ROCE)		 9.09% 7.16% 10.11%
Return on Equity Simple (ROE_SIMPLE)		 9.21% 7.66% 10.71%
Net Operating Profit after Tax (NOPAT)		 31 31 37
NOPAT Margin		 33.84% 32.64% 37.16%
Net Nonoperating Expense Percent (NNEP)		 2.85% 4.48% 4.83%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 66.16% 67.36% 62.84%
Earnings before Interest and Taxes (EBIT)		 31 31 37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 58 59 65
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 2.51 2.77 2.87
Price to Tangible Book Value (P/TBV)		 2.62 2.90 2.99
Price to Revenue (P/Rev)		 6.35 5.83 5.20
Price to Earnings (P/E)		 27.29 36.09 26.79
Dividend Yield		 6.81% 7.16% 7.85%
Earnings Yield		 3.66% 2.77% 3.73%
Enterprise Value to Invested Capital (EV/IC)		 1.59 1.62 1.60
Enterprise Value to Revenue (EV/Rev)		 10.05 9.51 8.85
Enterprise Value to EBITDA (EV/EBITDA)		 15.78 15.27 13.52
Enterprise Value to EBIT (EV/EBIT)		 29.71 29.15 23.82
Enterprise Value to NOPAT (EV/NOPAT)		 29.71 29.15 23.82
Enterprise Value to Operating Cash Flow (EV/OCF)		 19.46 21.12 18.68
Enterprise Value to Free Cash Flow (EV/FCFF)		 39.90 21.27 17.74
Leverage & Solvency		 - - -
Debt to Equity		 1.50 1.79 2.05
Long-Term Debt to Equity		 0.20 0.16 0.11
Financial Leverage		 1.45 1.63 1.91
Leverage Ratio		 2.60 2.80 3.09
Compound Leverage Factor		 2.60 2.80 3.09
Debt to Total Capital		 59.94% 64.14% 67.22%
Short-Term Debt to Total Capital		 52.12% 58.28% 63.69%
Long-Term Debt to Total Capital		 7.82% 5.86% 3.53%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 40.06% 35.86% 32.78%
Debt to EBITDA		 5.94 6.05 5.68
Net Debt to EBITDA		 5.81 5.91 5.57
Long-Term Debt to EBITDA		 0.77 0.55 0.30
Debt to NOPAT		 11.18 11.55 10.01
Net Debt to NOPAT		 10.93 11.29 9.82
Long-Term Debt to NOPAT		 1.46 1.06 0.53
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 23 43 49
Operating Cash Flow to CapEx		 343.65% 563.50% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.15 0.16 0.17
Fixed Asset Turnover		 0.20 0.21 0.22
Capital & Investment Metrics		 - - -
Invested Capital		 572 560 548
Invested Capital Turnover		 0.16 0.17 0.18
Increase / (Decrease) in Invested Capital		 7.83 -12 -13
Enterprise Value (EV)		 911 907 876
Market Capitalization		 576 556 515
Book Value per Share		 $16.60 $14.54 $12.96
Tangible Book Value per Share		 $15.91 $13.88 $12.43
Total Capital		 572 560 548
Total Debt		 343 359 368
Total Long-Term Debt		 45 33 19
Net Debt		 335 351 361
Capital Expenditures (CapEx)		 14 7.62 0.00
Net Nonoperating Expense (NNE)		 9.56 16 18
Net Nonoperating Obligations (NNO)		 343 359 368
Total Depreciation and Amortization (D&A)		 27 28 28
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $1.53 $1.12 $1.39
Adjusted Weighted Average Basic Shares Outstanding		 13.77M 13.79M 13.80M
Adjusted Diluted Earnings per Share		 $1.53 $1.11 $1.39
Adjusted Weighted Average Diluted Shares Outstanding		 13.80M 13.81M 13.84M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.80M 13.82M 13.85M
Normalized Net Operating Profit after Tax (NOPAT)		 21 22 26
Normalized NOPAT Margin		 23.69% 22.85% 26.01%
Pre Tax Income Margin		 33.84% 32.64% 37.16%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 185.66% 258.21% 210.01%
Augmented Payout Ratio		 185.66% 258.21% 210.01%

Quarterly Metrics And Ratios for Universal Health Realty Income Trust

This table displays calculated financial ratios and metrics derived from Universal Health Realty Income Trust's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 4.46% 12.70% 4.74% 7.37% 9.35% -0.17% 8.25% 3.90% 1.12% 2.30%
EBITDA Growth		 -0.79% 38.19% 21.16% 22.88% 7.59% -23.19% 13.06% 15.14% 3.08% 5.69%
EBIT Growth		 0.41% 80.16% 51.08% 51.53% 9.62% -40.51% 21.55% 29.79% 5.79% 16.86%
NOPAT Growth		 0.41% 18.08% 5.56% 1.99% 9.62% -9.24% 21.55% 29.79% 5.79% 16.86%
Net Income Growth		 -9.28% -93.85% -17.50% -33.38% -20.13% -36.19% 18.86% 51.78% 3.23% 29.72%
EPS Growth		 -10.26% -93.83% -17.95% -34.21% -20.00% -36.59% 18.75% 52.00% 3.57% 30.77%
Operating Cash Flow Growth		 -11.32% 6.57% -13.98% -7.42% 6.12% -14.92% 16.59% -1.04% -2.65% 25.81%
Free Cash Flow Firm Growth		 -170.31% 100.87% 105.73% 110.20% 113.49% 2,068.56% 217.95% 156.26% 181.04% 12.41%
Invested Capital Growth		 18.10% 1.39% 0.40% -0.33% -0.50% -2.02% -1.42% -2.50% -3.87% -2.25%
Revenue Q/Q Growth		 -0.09% 8.93% -3.74% 2.50% 1.75% -0.56% 4.37% -1.62% -0.97% 0.60%
EBITDA Q/Q Growth		 20.69% 41.50% -27.24% -1.10% 5.67% 1.01% 7.09% 0.72% -5.39% 3.58%
EBIT Q/Q Growth		 50.24% 81.93% -41.55% -5.15% 8.68% -1.27% 19.44% 1.28% -11.41% 9.06%
NOPAT Q/Q Growth		 1.12% 19.25% -10.82% -5.15% 8.68% -1.27% 19.44% 1.28% -11.41% 9.06%
Net Income Q/Q Growth		 -7.09% 16.15% -20.81% -22.05% 11.39% -7.21% 47.51% -0.45% -24.24% 16.61%
EPS Q/Q Growth		 -7.89% 17.14% -21.95% -21.88% 12.00% -7.14% 46.15% 0.00% -23.68% 17.24%
Operating Cash Flow Q/Q Growth		 -27.65% 28.33% -18.07% 21.71% -17.07% 2.88% 12.27% 3.31% -18.42% 32.95%
Free Cash Flow Firm Q/Q Growth		 11.34% 101.11% 514.94% 68.29% 17.16% 78.85% -9.84% 35.64% 28.49% -28.46%
Invested Capital Q/Q Growth		 0.76% -0.36% -0.22% -0.51% 0.59% -1.88% 0.40% -1.61% -0.82% -0.23%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 63.69% 82.73% 62.53% 60.33% 62.66% 63.65% 65.31% 66.86% 63.87% 65.76%
EBIT Margin		 33.05% 55.20% 33.52% 31.02% 33.13% 32.89% 37.64% 38.75% 34.66% 37.57%
Profit (Net Income) Margin		 21.89% 23.34% 19.20% 14.60% 15.98% 14.92% 21.08% 21.33% 16.32% 18.91%
Tax Burden Percent		 66.22% 64.50% 57.28% 47.07% 48.25% 45.35% 56.01% 55.05% 47.08% 50.34%
Interest Burden Percent		 100.00% 65.55% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 5.48% 5.77% 5.40% 5.09% 5.52% 5.54% 6.46% 6.79% 6.09% 6.71%
ROIC Less NNEP Spread (ROIC-NNEP)		 4.75% 4.85% 4.42% 3.95% 4.33% 4.31% 5.30% 5.58% 4.86% 5.45%
Return on Net Nonoperating Assets (RNNOA)		 8.31% 7.01% 6.54% 6.01% 6.85% 7.03% 9.04% 9.78% 9.03% 10.42%
Return on Equity (ROE)		 13.79% 12.79% 11.94% 11.09% 12.37% 12.57% 15.50% 16.56% 15.12% 17.14%
Cash Return on Invested Capital (CROIC)		 -11.06% 4.02% 5.06% 5.82% 6.07% 7.53% 7.21% 8.78% 10.27% 8.92%
Operating Return on Assets (OROA)		 5.16% 8.30% 5.09% 4.80% 5.19% 5.21% 6.10% 6.40% 5.72% 6.32%
Return on Assets (ROA)		 3.41% 3.51% 2.92% 2.26% 2.51% 2.36% 3.42% 3.52% 2.70% 3.18%
Return on Common Equity (ROCE)		 13.79% 12.79% 11.94% 11.09% 12.37% 12.57% 15.50% 16.56% 15.12% 17.14%
Return on Equity Simple (ROE_SIMPLE)		 45.84% 0.00% 9.07% 8.50% 8.29% 0.00% 8.27% 9.46% 10.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 7.32 8.73 7.79 7.38 8.03 7.92 9.46 9.58 8.49 9.26
NOPAT Margin		 33.05% 36.18% 33.52% 31.02% 33.13% 32.89% 37.64% 38.75% 34.66% 37.57%
Net Nonoperating Expense Percent (NNEP)		 0.73% 0.92% 0.98% 1.14% 1.18% 1.23% 1.17% 1.21% 1.23% 1.26%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 66.95% 44.80% 66.48% 68.98% 66.87% 67.11% 62.36% 61.25% 65.34% 62.43%
Earnings before Interest and Taxes (EBIT)		 7.32 13 7.79 7.38 8.03 7.92 9.46 9.58 8.49 9.26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 14 20 15 14 15 15 16 17 16 16
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 2.28 2.51 2.74 2.82 2.48 2.77 2.53 2.84 3.49 2.87
Price to Tangible Book Value (P/TBV)		 2.38 2.62 2.86 2.94 2.59 2.90 2.65 2.96 3.64 2.99
Price to Revenue (P/Rev)		 6.05 6.35 6.65 6.56 5.46 5.83 5.12 5.51 6.44 5.20
Price to Earnings (P/E)		 4.97 27.29 30.24 33.22 29.86 36.09 30.66 29.99 34.88 26.79
Dividend Yield		 7.34% 6.81% 6.45% 6.45% 7.62% 7.16% 8.02% 7.41% 6.36% 7.85%
Earnings Yield		 20.13% 3.66% 3.31% 3.01% 3.35% 2.77% 3.26% 3.33% 2.87% 3.73%
Enterprise Value to Invested Capital (EV/IC)		 1.51 1.59 1.66 1.68 1.53 1.62 1.52 1.62 1.81 1.60
Enterprise Value to Revenue (EV/Rev)		 9.83 10.05 10.36 10.22 9.15 9.51 8.80 9.15 10.10 8.85
Enterprise Value to EBITDA (EV/EBITDA)		 16.55 15.78 15.76 15.14 13.64 15.27 13.97 14.16 15.56 13.52
Enterprise Value to EBIT (EV/EBIT)		 34.93 29.71 28.53 26.62 23.91 29.15 26.11 25.67 28.05 23.82
Enterprise Value to NOPAT (EV/NOPAT)		 29.46 29.71 30.57 30.54 27.35 29.15 26.11 25.67 28.05 23.82
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.77 19.46 21.03 21.58 19.50 21.12 19.20 20.20 22.50 18.68
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 39.90 32.97 28.79 25.11 21.27 20.95 18.26 17.29 17.74
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 1.46 1.50 1.57 1.62 1.72 1.79 1.86 1.90 2.02 2.05
Long-Term Debt to Equity		 0.22 0.20 0.18 0.18 0.19 0.16 0.17 0.10 0.11 0.11
Financial Leverage		 1.75 1.45 1.48 1.52 1.58 1.63 1.71 1.75 1.86 1.91
Leverage Ratio		 2.92 2.60 2.63 2.67 2.74 2.80 2.87 2.92 3.04 3.09
Compound Leverage Factor		 2.92 1.70 2.63 2.67 2.74 2.80 2.87 2.92 3.04 3.09
Debt to Total Capital		 59.30% 59.94% 61.07% 61.85% 63.18% 64.14% 65.08% 65.55% 66.92% 67.22%
Short-Term Debt to Total Capital		 50.54% 52.12% 54.04% 54.85% 56.29% 58.28% 59.30% 61.94% 63.34% 63.69%
Long-Term Debt to Total Capital		 8.75% 7.82% 7.03% 7.00% 6.88% 5.86% 5.78% 3.61% 3.58% 3.53%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 40.70% 40.06% 38.93% 38.16% 36.82% 35.86% 34.92% 34.45% 33.08% 32.78%
Debt to EBITDA		 6.52 5.94 5.78 5.58 5.64 6.05 5.97 5.72 5.75 5.68
Net Debt to EBITDA		 6.36 5.81 5.65 5.43 5.51 5.91 5.85 5.63 5.65 5.57
Long-Term Debt to EBITDA		 0.96 0.77 0.67 0.63 0.61 0.55 0.53 0.31 0.31 0.30
Debt to NOPAT		 11.60 11.18 11.22 11.25 11.30 11.55 11.17 10.37 10.36 10.01
Net Debt to NOPAT		 11.33 10.93 10.95 10.94 11.04 11.29 10.93 10.21 10.18 9.82
Long-Term Debt to NOPAT		 1.71 1.46 1.29 1.27 1.23 1.06 0.99 0.57 0.55 0.53
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -81 0.90 5.52 9.28 11 19 18 24 31 22
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 133.75% 47,522.73% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.16 0.15 0.15 0.15 0.16 0.16 0.16 0.17 0.17 0.17
Fixed Asset Turnover		 0.19 0.20 0.20 0.20 0.21 0.21 0.21 0.22 0.22 0.22
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 574 572 571 568 571 560 563 554 549 548
Invested Capital Turnover		 0.17 0.16 0.16 0.16 0.17 0.17 0.17 0.18 0.18 0.18
Increase / (Decrease) in Invested Capital		 88 7.83 2.27 -1.90 -2.85 -12 -8.08 -14 -22 -13
Enterprise Value (EV)		 864 911 950 953 873 907 856 898 995 876
Market Capitalization		 532 576 609 612 521 556 498 541 634 515
Book Value per Share		 $16.93 $16.60 $16.10 $15.69 $15.22 $14.54 $14.24 $13.79 $13.12 $12.96
Tangible Book Value per Share		 $16.21 $15.91 $15.45 $15.09 $14.52 $13.88 $13.62 $13.20 $12.56 $12.43
Total Capital		 574 572 571 568 571 560 563 554 549 548
Total Debt		 340 343 349 351 361 359 366 363 367 368
Total Long-Term Debt		 50 45 40 40 39 33 33 20 20 19
Net Debt		 332 335 340 342 352 351 358 357 361 361
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 7.60 0.02 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 2.47 3.10 3.33 3.91 4.15 4.33 4.16 4.31 4.49 4.60
Net Nonoperating Obligations (NNO)		 340 343 349 351 361 359 366 363 367 368
Total Depreciation and Amortization (D&A)		 6.79 6.64 6.74 6.98 7.15 7.41 6.96 6.95 7.16 6.95
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.35 $0.41 $0.32 $0.25 $0.28 $0.27 $0.38 $0.38 $0.29 $0.34
Adjusted Weighted Average Basic Shares Outstanding		 13.78M 13.77M 13.78M 13.78M 13.79M 13.79M 13.79M 13.80M 13.81M 13.80M
Adjusted Diluted Earnings per Share		 $0.35 $0.41 $0.32 $0.25 $0.28 $0.26 $0.38 $0.38 $0.29 $0.34
Adjusted Weighted Average Diluted Shares Outstanding		 13.80M 13.80M 13.80M 13.81M 13.82M 13.81M 13.82M 13.83M 13.85M 13.84M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.80M 13.80M 13.80M 13.82M 13.82M 13.82M 13.83M 13.85M 13.85M 13.85M
Normalized Net Operating Profit after Tax (NOPAT)		 5.12 6.11 5.45 5.17 5.62 5.55 6.62 6.71 5.94 6.48
Normalized NOPAT Margin		 23.14% 25.33% 23.46% 21.71% 23.19% 23.02% 26.35% 27.12% 24.26% 26.30%
Pre Tax Income Margin		 33.05% 36.18% 33.52% 31.02% 33.13% 32.89% 37.64% 38.75% 34.66% 37.57%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 36.45% 185.66% 195.10% 214.34% 227.19% 258.21% 245.76% 222.18% 221.51% 210.01%
Augmented Payout Ratio		 36.45% 185.66% 195.10% 214.34% 227.19% 258.21% 245.76% 222.18% 221.51% 210.01%

Financials Breakdown Chart

Key Financial Trends

Universal Health Realty Income Trust (NYSE:UHT) showed a generally stable operating profile over the last several years, with modest but consistent quarterly profitability and recurring cash generation. However, the trend also shows pressure from a heavy debt load, high dividend commitments, and limited balance sheet flexibility.

  • Quarterly revenue has stayed very steady, hovering around the mid-$20 million range from 2023 through 2024, suggesting a relatively predictable business model.
  • Operating cash flow remained solid in 2024, with Q4 operating cash flow of $13.2 million, up from $9.9 million in Q3 and $12.1 million in Q2.
  • Net income improved in 2024 versus late 2023, with Q4 consolidated net income of $4.7 million compared with $3.6 million in Q4 2023.
  • Earnings per share also edged higher year over year, with Q4 2024 basic and diluted EPS at $0.34 versus $0.27 in Q4 2023.
  • Depreciation and amortization continue to generate meaningful non-cash add-backs, helping support strong operating cash flow relative to net income.
  • Cash and equivalents increased slightly in Q4 2024, ending the quarter at $7.1 million after a positive net change in cash of $725,000.
  • The company’s revenue base is heavily dependent on non-interest income and other service-related revenue rather than a diversified mix of operating segments.
  • Share count has remained very stable, with weighted average diluted shares near 13.8 million across the periods presented, limiting dilution risk.
  • The balance sheet has remained relatively consistent in total assets, staying around the high-$500 million to low-$600 million range over the last four years.
  • Dividend payments are large and persistent, including $10.2 million in Q4 2024 and roughly $10.0 million in each of the prior quarters shown, which consumes most of operating cash flow.
  • Debt remains a major concern. Q3 2024 showed $347.8 million in short-term debt, and while it declined to $317.7 million by Q4 2024, leverage is still substantial relative to equity.
  • Interest burden is significant, with cash interest paid of $4.8 million in Q4 2024 and $4.9 million in Q3 2024.
  • Book equity has been volatile and relatively thin versus liabilities, with total equity of $181.6 million in Q3 2024 versus liabilities of $402.7 million.
  • Net cash from financing activities was negative in every quarter shown, reflecting ongoing dividend outflows and debt repayments that exceed new financing.
  • The company’s net income does not fully translate into retained earnings growth, as recurring dividend payments continue to pressure retained earnings over time.

Overall, UHT looks like a steady income-producing REIT with dependable quarterly cash flow and fairly stable earnings, but the stock still carries meaningful financial risk because of its debt load and the amount of cash required to support its dividend. For retail investors, the key question is whether that dividend remains comfortably covered after debt service and capital needs.

06/06/26 07:32 PM ETAI Generated. May Contain Errors.

Universal Health Realty Income Trust Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Universal Health Realty Income Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

Universal Health Realty Income Trust's net income appears to be on a downward trend, with a most recent value of $19.23 million in 2024, falling from $21.10 million in 2022. The previous period was $15.40 million in 2023. View Universal Health Realty Income Trust's forecast to see where analysts expect Universal Health Realty Income Trust to go next.

Over the last 2 years, Universal Health Realty Income Trust's total revenue changed from $90.63 million in 2022 to $99.01 million in 2024, a change of 9.3%.

Universal Health Realty Income Trust's total liabilities were at $401.32 million at the end of 2024, a 1.5% increase from 2023, and a 6.0% increase since 2022.

In the past 2 years, Universal Health Realty Income Trust's cash and equivalents has ranged from $7.10 million in 2024 to $8.21 million in 2023, and is currently $7.10 million as of their latest financial filing in 2024.

Over the last 2 years, Universal Health Realty Income Trust's book value per share changed from 16.60 in 2022 to 12.96 in 2024, a change of -21.9%.


Related Companies

Financial statements for NYSE:UHT last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
BUY THIS: Claim a backdoor stake in SpaceX before June 12
Marc Chaikin, the Wall Street veteran who spotted Nvidia before a 45,000% run, says there's a simple trade ava...
Chaikin Analytics | Sponsoredtc pixel
How to get into the SpaceX IPO before June 12
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel